DIY Healthcare Outpaces Retail, Medicinal Cannabis Sales Drop 30%, and Chronic Pain Marketing Needs a Reset – Week of 20 April 2026

Welcome to this week’s Digital Health Observer. The common thread across this edition is consumer power reshaping health markets, from runaway self-directed spending in the US to Australian regulators reining in a prescribing boom. Here is what caught our attention.

Consumers Spend More on DIY Healthcare Than Ever

Circana’s latest State of Consumer Healthcare report shows US household spending on self-directed health, beyond insurance premiums and hospital bills, is now growing faster than overall retail. GLP-1s, women’s health, mental wellness and longevity products are all driving the surge. Read more →

Medicinal Cannabis Sales in Australia Drop 30% After Enforcement Push

Medicinal cannabis units sold in Australia fell from 3.70 million in the first half of 2025 to 2.65 million in the second half after AHPRA and the TGA clarified prescriber and dispenser rules and stepped up monitoring. It is the first sustained decline since legalisation in 2016. Read more →

Chronic Pain Marketing Is Stuck on Acute-Pain Clichés

Chronic pain advocate Mara Baer says most campaigns still rely on acute-pain stock imagery such as people gripping their backs or grimacing construction workers. She calls on marketers to drop ‘sufferer’ language, retire the stock pain photography, and depict people functioning with the condition. Read more →

Western Australia Now Holds 13 of Australia’s Top 20 ADHD-Prescribing Neighbourhoods

2024-25 dispensing data analysed by the University of NSW places 13 WA neighbourhoods in Australia’s top 20 for adult ADHD prescriptions, from affluent Fremantle and Cottesloe to lower-income Mandurah and Bunbury. Other states’ hotspots are concentrated in high-advantage suburbs only. Read more →